325 related articles for article (PubMed ID: 15102806)
1. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
[TBL] [Abstract][Full Text] [Related]
2. Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".
Yano J; Peters BM; Noverr MC; Fidel PL
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203543
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.
Bruno VM; Shetty AC; Yano J; Fidel PL; Noverr MC; Peters BM
mBio; 2015 Apr; 6(2):. PubMed ID: 25900651
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.
Yano J; Noverr MC; Fidel PL
Cytokine; 2012 Apr; 58(1):118-28. PubMed ID: 22182685
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of recurrent vulvovaginal candidiasis.
Fidel PL; Sobel JD
Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
Yano J; Noverr MC; Fidel PL
mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
[TBL] [Abstract][Full Text] [Related]
7. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
[TBL] [Abstract][Full Text] [Related]
8. Microbicidal activity of neutrophils is inhibited by isolates from recurrent vaginal candidiasis (RVVC) caused by Candida albicans through fungal thioredoxin reductase.
Ratti BA; Godoy JS; de Souza Bonfim Mendonça P; Bidóia DL; Nakamura TU; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; de Oliveira Silva S
Cell Immunol; 2015 Jan; 293(1):22-9. PubMed ID: 25497972
[TBL] [Abstract][Full Text] [Related]
9. History and update on host defense against vaginal candidiasis.
Fidel PL
Am J Reprod Immunol; 2007 Jan; 57(1):2-12. PubMed ID: 17156186
[TBL] [Abstract][Full Text] [Related]
10. Immunity in vaginal candidiasis.
Fidel PL
Curr Opin Infect Dis; 2005 Apr; 18(2):107-11. PubMed ID: 15735412
[TBL] [Abstract][Full Text] [Related]
11. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
[TBL] [Abstract][Full Text] [Related]
12. [Local humoral immunity in vulvovaginal candidiasis].
Amouri I; Hadrich I; Abbes S; Sellami H; Ayadi A
Ann Biol Clin (Paris); 2013; 71(2):151-5. PubMed ID: 23587578
[TBL] [Abstract][Full Text] [Related]
13. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
14. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
Cassone A
BJOG; 2015 May; 122(6):785-794. PubMed ID: 25052208
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
17. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
18. Methods Related to the Immunopathogenesis of Vulvovaginal Candidiasis and Associated Neutrophil Anergy.
Yano J; Fidel PL
Methods Mol Biol; 2022; 2542():193-218. PubMed ID: 36008666
[TBL] [Abstract][Full Text] [Related]
19. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
20. Distinct protective host defenses against oral and vaginal candidiasis.
Fidel PL
Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
